Abliva AB – Trademark Portfolio
Entity Type: 16
Abliva AB holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 6 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 5 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include NP, ABLIVA, NEUROSTAT, NEUROVIVE, and NP NEUROVIVE PHARMACEUTICAL.
Medicon Village,
Scheelev?gen 2 SE-223 81 Lund
Showing of trademarks Trademarks
Trademark Classifications
Abliva AB's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Abliva AB have?
Abliva AB has 8 U.S. trademarks filed with the USPTO. Of these, 5 registered.
What trademark classes does Abliva AB file in?
Abliva AB files trademarks across 5 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Abliva AB's most well-known trademarks?
Abliva AB's registered trademark portfolio includes well-known marks such as NP, ABLIVA, NEUROSTAT, NEUROVIVE, and NP NEUROVIVE PHARMACEUTICAL. These are among 5 currently registered trademarks in the portfolio.
What is Abliva AB's trademark registration success rate?
Abliva AB has a 100% trademark registration rate, with 5 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.